Search by Drug Name or NDC

    NDC 61269-0380-12 PYLERA 140; 125; 125 mg/1; mg/1; mg/1 Details

    PYLERA 140; 125; 125 mg/1; mg/1; mg/1

    PYLERA is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma, LLC. The primary component is BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE.

    Product Information

    NDC 61269-0380
    Product ID 61269-380_e0ed7e4a-7b77-488c-9864-e09e4dad8289
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name PYLERA
    Proprietary Name Suffix n/a
    Non-Proprietary Name BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 140; 125; 125
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
    Labeler Name H2-Pharma, LLC
    Pharmaceutical Class Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050786
    Listing Certified Through 2024-12-31

    Package

    NDC 61269-0380-12 (61269038012)

    NDC Package Code 61269-380-12
    Billing NDC 61269038012
    Package 10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2023-10-01
    NDC Exclude Flag N
    Pricing Information N/A